| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |